# A Study of RPT1G After Single and Multiple Doses in Healthy Adult Participants

> **NCT06667765** · PHASE1 · COMPLETED · sponsor: **Remedy Plan, Inc.** · enrollment: 56 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** RPT1G
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06667765
- **Lead sponsor:** Remedy Plan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-18
- **Primary completion:** 2025-05-14
- **Final completion:** 2025-05-14
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06667765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06667765, "A Study of RPT1G After Single and Multiple Doses in Healthy Adult Participants". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06667765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*